NCT05722756

Brief Summary

This observational, retrospective study has shown, that the addition of craniosacral therapy to the Vojta method has improved the effects of the therapy in 6 months follow-up period. The chance for improvement was 9.42 times higher in Vojta + craniosacral group compared to the group conducted only with Vojta method. The study results suggest that the craniosacral procedure should be considered as an additive regimen to the Vojta method in the therapy of children with central coordination disorders (CCD) . More data is still needed to improve the rehabilitation process in this group of patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2014

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2019

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

January 20, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 10, 2023

Completed
Last Updated

February 10, 2023

Status Verified

February 1, 2023

Enrollment Period

5.9 years

First QC Date

January 20, 2023

Last Update Submit

February 1, 2023

Conditions

Keywords

childrenrehabilitationcentral nervous systemVojta therapycranio-sacral therapyreflex locomotion

Outcome Measures

Primary Outcomes (1)

  • Changes in the number of abnormal reactions (assessed by the Vojta tests)

    improvement: fewer number of the abnormal reactions present when compare to the first visit no improvement- at least the same number (or more) of abnormal reactions present when compare to the first visit

    6 months

Study Arms (2)

group A

treated with Vojta therapy

group B

treated with Vojta therapy combined with craniosacral therapy

Other: craniosacral therapy

Interventions

subtle form of applied touch, type of osteopathy

group B

Eligibility Criteria

Age1 Month - 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children with confirmed CCD (central coordination disorders), between 1-6 months of age

You may qualify if:

  • CCD (central coordination disorders) diagnosis based on the paediatrician's opinion with a decision that the child needs rehabilitation;
  • a score of 8- 10 on the APGAR scale in the first minute of life;
  • no major birth defects documented that can push the diagnosis into the diagnosis of genetic disorders;
  • the age of the child at the time of the assessment of its eligibility for rehabilitation: 1-6 months (of life), calculated based on completed months of life;
  • available information regarding an abnormal result of the Vojta test, defined as at least 6 abnormal reactions (marked as abnormal \[AN\], or delayed \[OP\] in the test report) with abnormal muscle tension, which indicates moderate to severe CCD;
  • available information regarding the first medical examination (during the first visit (W0)), and a follow-up visit after 6 months (W6) on the determined date, maintaining the defined timeframe (5.5-6 months after W0).

You may not qualify if:

  • children who obtained a score of \< 8 points on the APGAR scale in the first minute of life;
  • suspicion of any major (significant) birth defect, congenital defect syndrome (e.g. Down syndrome, Sotos syndrome) and/or indications for consultation at Genetics Clinic based on paediatric records;
  • age \< 1 month or \> 6 months;
  • \< 6 abnormal reactions during the Vojta test at the first eligibility visit, which indicates mild or very mild CCD.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Central Nervous System Diseases

Condition Hierarchy (Ancestors)

Nervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2023

First Posted

February 10, 2023

Study Start

January 1, 2014

Primary Completion

November 30, 2019

Study Completion

November 30, 2019

Last Updated

February 10, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will share

all IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
after publication, no limit
Access Criteria
to everyone via the link below
More information